Enhanced global surveillance by the WHO and CDC, combined with the absence of highly transmissible novel pathogens capable of sustained human-to-human spread, underpins traders' strong consensus against a new pandemic by 2028. Regional Ebola Bundibugyo outbreaks in the DRC, while declared a public health emergency of international concern with thousands of cases, remain geographically contained with no evidence of pandemic-scale potential. Similar patterns hold for hantavirus, mpox, and seasonal influenza threats, which lack the transmissibility or virulence thresholds seen in prior pandemics. Post-COVID improvements in diagnostics, contact tracing, and vaccine platforms further reduce escalation risks, though uneven funding and geopolitical factors introduce some uncertainty ahead of routine monitoring updates.